Study of Binocular Computer Activities for Treatment of Amblyopia
ATS18
2 other identifiers
interventional
485
1 country
2
Brief Summary
The purpose of the study is to compare the effectiveness of 1 hour/day of binocular game play 7 days per week with 2 hours/day patching 7 days per week in children 5 to \<17
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2014
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2014
CompletedFirst Posted
Study publicly available on registry
July 25, 2014
CompletedStudy Start
First participant enrolled
September 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 19, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 19, 2016
CompletedResults Posted
Study results publicly available
October 15, 2018
CompletedFebruary 27, 2019
February 1, 2019
1.9 years
July 23, 2014
March 1, 2018
February 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in Distance Visual Acuity From Baseline in the Younger Cohort (5 to <13 Years)
Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children \<7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA. Change in VA is computed as logMAR lines (positive values indicate improvement), defined as the difference between the enrollment and 16-week acuities (logMAR) multiplied by 10.
Baseline and 16 weeks
Mean Amblyopic Eye Visual Acuity (Younger Cohort)
Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children \<7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA.
16 Weeks from baseline
Mean Change in Amblyopic-eye Visual Acuity in the Older Cohort (13 to <17 Years)
Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up.
Baseline and 16 weeks
Mean Amblyopic-eye Visual Acuity in the Older Cohort (13 to <17 Years)
Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up.
16 weeks
Distribution of Change in Amblyopic-eye Visual Acuity
Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children \<7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined).
Baseline and 16 weeks
Distribution of Amblyopic-eye Visual Acuity
Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children \<7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined).
At 16 weeks
Secondary Outcomes (12)
Number of Participants With Amblyopic-eye VA Improvement of 2 or More logMAR Lines (10 or More Letters if E-ETDRS) From Baseline
Baseline and 16-week visit
Number of Participants With Resolution of Amblyopia
16-week visit
Time Course of Visual Acuity Improvement
Baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks
Younger Cohort: Change in Distance Visual Acuity From Baseline According to Subgroups
Baseline and 16 weeks
Older Cohort: Change in Distance Visual Acuity From Baseline According to Subgroups
Baseline and 16 weeks
- +7 more secondary outcomes
Other Outcomes (10)
Percentage of Participants Reporting >75% of Prescribed Treatment Completed (Subjective Measures of Adherence)
16 Weeks from baseline
Participants Who Received Non-protocol, Alternative Treatment During the Study
Entire study period, up to 16 weeks
Safety Analysis: Distribution of the Change in Fellow-eye Visual Acuity From Baseline
16-week visit
- +7 more other outcomes
Study Arms (2)
Binocular Treatment
EXPERIMENTALBinocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week)
Patching Treatment
ACTIVE COMPARATORPatching 2 hours per day, 7 days per week
Interventions
Eligibility Criteria
You may qualify if:
- Age 5 to \<17 years
- Amblyopia associated with strabismus, anisometropia, or both (previously treated or untreated)
- Criteria for strabismus: At least one of the following must be met:
- Presence of a heterotropia on examination at distance or near fixation (with or without spectacles)
- Documented history of strabismus which is no longer present (which in the judgment of the investigator could have caused amblyopia)
- Criteria for anisometropia: At least one of the following criteria must be met:
- ≥0.50 diopter (D) difference between eyes in spherical equivalent
- ≥1.50 D difference between eyes in astigmatism in any meridian
- Criteria for combined-mechanism amblyopia: Both of the following criteria must be met:
- Criteria for strabismus are met (see above)
- ≥1.00 D difference between eyes in spherical equivalent OR ≥1.50 D difference between eyes in astigmatism in any meridian
- Note: the spherical equivalent requirement differs from that in the definition for refractive/anisometropic amblyopia
- No amblyopia treatment in the past 2 weeks (patching, atropine, Bangerter, vision therapy)
- Refractive correction (spectacles or contact lenses, if applicable) must meet the following criteria at enrollment and be based on a cycloplegic refraction that is not more than 7 months old.
- Requirements for Correction of Refractive Error:
- +22 more criteria
You may not qualify if:
- A subject is excluded for any of the following reasons:
- Prism in the refractive correction at time of enrollment (eligible only if prism is discontinued 2 weeks prior to enrollment).
- Myopia greater than -6.00 D spherical equivalent in either eye.
- Previous intraocular or refractive surgery.
- Any treatment for amblyopia (patching, atropine, Bangerter filter, or vision therapy) during the past 2 weeks. Previous amblyopia therapy is allowed regardless of type, but must be discontinued at least 2 weeks immediately prior to enrollment.
- Ocular co-morbidity that may reduce visual acuity determined by an ocular examination performed within the past 7 months (Note: nystagmus per se does not exclude the subject if the above visual acuity criteria are met).
- No Down syndrome or cerebral palsy
- No severe developmental delay that would interfere with treatment or evaluation (in the opinion of the investigator). Subjects with mild speech delay or reading and/or learning disabilities are not excluded.
- Heterotropia or heterophoria with a total ocular deviation \>10∆ (phoria plus tropia \>10∆) at near (measured by PACT).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jaeb Center for Health Researchlead
- Pediatric Eye Disease Investigator Groupcollaborator
- National Eye Institute (NEI)collaborator
Study Sites (2)
Mayo Clinic
Rochester, Minnesota, 55905, United States
Seattle Children's Hospital, University of Washington
Seattle, Washington, 98105, United States
Related Publications (2)
Holmes JM, Manh VM, Lazar EL, Beck RW, Birch EE, Kraker RT, Crouch ER, Erzurum SA, Khuddus N, Summers AI, Wallace DK; Pediatric Eye Disease Investigator Group. Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 1;134(12):1391-1400. doi: 10.1001/jamaophthalmol.2016.4262.
PMID: 27812703RESULTTailor V, Ludden S, Bossi M, Bunce C, Greenwood JA, Dahlmann-Noor A. Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years. Cochrane Database Syst Rev. 2022 Feb 7;2(2):CD011347. doi: 10.1002/14651858.CD011347.pub3.
PMID: 35129211DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center
- Organization
- Jaeb Center for Health Research
Study Officials
- STUDY CHAIR
Jonathan Holmes, MD
Mayo Clinic
- STUDY CHAIR
Vivan Manh, OD
University of Washington
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2014
First Posted
July 25, 2014
Study Start
September 11, 2014
Primary Completion
August 19, 2016
Study Completion
August 19, 2016
Last Updated
February 27, 2019
Results First Posted
October 15, 2018
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After primary manuscripts are published
- Access Criteria
- Users accessing the data must enter an email address.
In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.